Professor Gary Hull, director of the Program on Values and Ethics in the Marketplace of Duke University, will present a moral defense of the pharmaceutical industry's unconditional right to patents. Hull argues that this right is being violated by price caps, state-imposed limits on pharmaceutical advertising, and educational programs, compulsory licensing, special favors for generics, and limits on ancillary patents. Sponsored by Duke Law IPCS. For more information, contact Elizabeth Laughton at email@example.com.
The Moral Right to Pharmaceutical Patents
- Roberts '00 appointed to N.C. Ethics Commission N.C. Office of the Governor
- Hoffman '92 named Rutgers University's senior vice president and general counsel Rutgers Today
- Azar ’99 argues Ninth Circuit appeal on behalf of Citi borrowers seeking class certification over bank’s failure to modify mortgages Law360